| Literature DB >> 22073004 |
Chih-Hua Chao1,2, Kuei-Ju Chou1, Chiung-Yao Huang1, Zhi-Hong Wen1,3, Chi-Hsin Hsu1,3, Yang-Chang Wu4, Chang-Feng Dai5, Jyh-Horng Sheu1,3.
Abstract
Eight new cembranoids, crassarines A-H (1-8) were isolated from the Formosan soft coral Sinularia crassa. Compounds 1-3 represent the rare cembranoids with a 1,12-oxa-bridged tetrahydrofuran ring, while 4 and 5 are the firstly discovered 1,11-oxa-bridged tetrahydropyranocembranoids. The absolute configuration of 6 was determined using the Mosher's method. Compounds 6 and 8 were found to significantly inhibit the expression of both pro-inflammatory iNOS and COX-2 proteins at 10 μM, respectively, while compounds 4-8 were found to be non-cytotoxic toward the selected human liver cancer cells.Entities:
Keywords: Sinularia crassa; anti-inflammatory; crassarines A-H
Mesh:
Substances:
Year: 2011 PMID: 22073004 PMCID: PMC3210613 DOI: 10.3390/md9101955
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 6.085
Chart 1The structures of crassarines A–H (1–8).
13C NMR spectroscopic data of compounds 1–8.
| # | 1 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 88.1 | 87.6 | 88.6 | 88.8 | 77.5 | 77.7 | 147.2 | 147.7 | 146.2 |
| 2 | 133.3 | 133.8 | 133.4 | 133.2 | 131.6 | 130.8 | 119.1 | 118.6 | 107.7 |
| 3 | 134.3 | 135.1 | 136.4 | 136.5 | 139.0 | 138.3 | 121.7 | 122.9 | 146.8 |
| 4 | 71.4 | 70.7 | 72.4 | 72.4 | 73.4 | 71.7 | 135.4 | 134.8 | 117.0 |
| 5 | 53.3 | 56.4 | 52.7 | 52.7 | 54.0 | 50.8 | 38.5 | 39.4 | 109.6 |
| 6 | 211.8 | 209.5 | 212.9 | 213.0 | 215.2 | 215.7 | 25.2 | 25.5 | 151.1 |
| 7 | 51.6 | 49.4 | 51.1 | 51.2 | 53.1 | 54.2 | 126.7 | 130.1 | 35.3 |
| 8 | 28.9 | 25.8 | 26.4 | 26.4 | 30.8 | 28.5 | 136.7 | 138.0 | 30.4 |
| 9 | 32.5 | 32.7 | 32.9 | 33.0 | 32.4 | 29.7 | 75.3 | 33.7 | 30.2 |
| 10 | 29.4 | 26.5 | 26.8 | 26.9 | 26.0 | 24.4 | 32.3 | 25.5 | 24.8 |
| 11 | 75.0 | 71.1 | 77.0 | 77.0 | 76.2 | 74.7 | 57.0 | 59.1 | 65.4 |
| 12 | 85.7 | 86.4 | 84.7 | 84.7 | 70.0 | 70.1 | 59.5 | 60.3 | 60.7 |
| 13 | 35.2 | 36.7 | 34.6 | 34.4 | 37.1 | 36.9 | 36.4 | 35.4 | 40.5 |
| 14 | 30.9 | 30.4 | 31.7 | 31.9 | 28.4 | 28.8 | 24.3 | 24.1 | 24.2 |
| 15 | 37.7 | 38.0 | 38.6 | 38.5 | 40.2 | 40.3 | 34.4 | 33.5 | 35.2 |
| 16 | 18.0 | 18.3 | 18.2 | 18.2 | 17.3 | 17.2 | 22.5 | 22.3 | 21.6 |
| 17 | 17.7 | 17.8 | 17.6 | 17.5 | 16.8 | 16.8 | 22.3 | 22.7 | 21.1 |
| 18 | 28.9 | 31.1 | 29.8 | 29.7 | 28.9 | 24.5 | 17.3 | 16.8 | 9.1 |
| 19 | 22.6 | 22.1 | 22.3 | 22.3 | 22.0 | 20.7 | 11.7 | 59.4 | 20.0 |
| 20 | 23.4 | 20.8 | 23.5 | 24.0 | 18.8 | 19.5 | 18.5 | 19.0 | 15.2 |
| OAc | 170.9 | ||||||||
| 21.0 | |||||||||
| CHO | 160.9 |
Spectra were measured in CDCl3 (100 MHz);
Spectra were measured in pyridine-d5 (100 MHz);
Spectra were measured in CDCl3 (125 MHz);
Spectra were measured in C6D6 (100 MHz).
Figure 1Selected 1H–1H COSY (—) and HMBC (→) correlations of 1–8.
Figure 2Selected NOE correlations for compounds 1, 4, 6, and 8.
1H NMR Spectroscopic Data of Compounds 1–3 and 8.
| # | 1, | 1, | 2, | 3, | 8, |
|---|---|---|---|---|---|
| 2 | 5.73, s | 6.28, d (16.0) | 5.75, s | 5.74, s | 5.95, s |
| 3 | 5.73, s | 6.04, d (16.0) | 5.75, s | 5.74, s | |
| 5 | a: 2.79, d (15.6) | a: 2.98, d (13.0) | a: 2.89, d (15.0) | a: 2.89, d (15.0) | 5.73,s |
| b: 2.61, d (15.6) | b: 2.87, d (13.0) | b: 2.48, d (15.0) | b: 2.48, d (15.0) | ||
| 7 | a: 2.45, dd (15.6, 8.4) | a: 3.38, dd (16.0, 4.0) | a: 2.52, dd (18.0, 8.5) | a: 2.49, dd (18.0, 8.5) | a: 2.44, br d (12.4) |
| b: 2.23, dd (15.6, 5.2) | b: 2.04, dd (16.0, 9.6) | b: 2.16, dd (18.0, 4.0) | b: 2.18, dd (18.0, 4.0) | b: 2.02, m | |
| 8 | 2.02, m | 2.41, m | 2.29, m | 2.29, m | 1.96, m |
| 9 | 1.46, m | 1.30, m | 1.37, m | 1.38, m | 1.30, m |
| 0.97, m | 0.99, m | 0.93, m | |||
| 10 | a: 1.56, m | a: 2.18, m | a: 1.44, m | a: 1.48, m | a: 1.82, m |
| b: 1.25, m | b: 1.63, m | b: 1.38, m | b: 1.37, m | b: 1.20, m | |
| 11 | 3.24, br d (9.6) | 3.76, d (10.4) | 4.80, br d (10.5) | 4.90, br d (8.4) | 2.36, dd (10.0, 2.0) |
| 13 | a: 1.98, m | a: 2.61, ddd (12.4, 8.4, 2.4) | a: 1.80, m | a: 1.84, m | a: 2.40, m |
| b: 1.68, m | b: 1.75, m | b: 1.60, m | b: 1.64, m | b: 1.04, m | |
| 14 | a: 1.96, m | a: 2.12, m | a: 1.98, m | a: 2.01, m | a: 3.55, dd (12.4, 9.2) |
| b: 1.89, m | b: 1.88, m | b: 1.87, m | b: 1.86, m | b: 2.02, m | |
| 15 | 1.76, m | 1.81, m | 1.75, m | 1.75, m | 2.22, m |
| 16 | 0.87, d (6.8) | 0.92, d (6.8) | 0.86, d (6.8) | 0.86, d (6.8) | 1.00, d (6.0) |
| 17 | 0.86, d (6.8) | 0.92, d (6.8) | 0.84, d (6.8) | 0.84, d (6.8) | 1.04, d (6.0) |
| 18 | 1.37, s | 1.61, s | 1.25, s | 1.25, s | 1.88, s |
| 19 | 0.98, d (6.4) | 0.94, d (6.8) | 0.91, d (6.4) | 0.92, d (6.8) | 0.82, d (6.4) |
| 20 | 1.25, s | 1.49, s | 1.15, s | 1.18, s | 1.23, s |
| OAc | 2.09, s | ||||
| CHO | 8.18,s | ||||
| 4-OH | 4.45, s | 4.47, s |
Spectra were measured in CDCl3 (400 MHz);
Spectra were measured in pyridine-d5 (400 MHz);
Spectra were measured in CDCl3 (500 MHz);
Spectra were measured in C6D6 (400 MHz).
1H NMR Spectroscopic Data of Compounds 4–7.
| # | 4 | 5 | 6 | 7 |
|---|---|---|---|---|
| 2 | 5.81, d (16.0) | 5.58, d (16.0) | 6.06, d (10.4) | 6.08, d (10.8) |
| 3 | 5.89, d (16.0) | 6.07, d (16.0) | 5.90, dd (10.4, 1.2) | 6.02, d (10.8) |
| 5 | a: 2.80, d (16.0) | a: 3.01, d (16.6) | 2.04, m | 2.00, m |
| b: 2.72, d (16.0) | b: 2.41, d (16.6) | |||
| 7 | a: 2.39, dd (13.6, 11.2) | a: 2.46, dd (11.6, 2.8) | 2.10, m | a: 2.13, m |
| b: 2.16, dd (13.6, 2.4) | b: 2.07, dd (12.0, 11.6) | b: 2.00, m | ||
| 8 | 1.92, m | 1.96, m | 5.50, dd (7.2, 6.0) | 5.26, dd (9.2, 5.2) |
| 9 | a: 1.32, m | a: 1.56, m | 4.00, dd (8.0, 3.2) | a: 2.36, m |
| b: 1.18, m | b: 0.99, m | b: 2.29, m | ||
| 10 | a: 1.49, m | a: 1.57, m | a: 1.99, m | a: 1.72, m |
| b: 1.19, m | b: 1.26, m | b: 1.67, m | b: 1.64, m | |
| 11 | 3.02, d (8.8) | 3.19, d (10.4) | 2.87, dd (7.6, 6.0) | 3.00, dd (6.8, 5.2) |
| 13 | a: 1.74, m | a: 1.72, m | a: 1.85, m | a: 1.91, m |
| b: 1.57, m | b: 1.51, m | b: 1.52, m | b: 1.62, m | |
| 14 | a: 1.68, m | a: 1.65, m | a: 2.23, m | a: 2.40, m |
| b: 1.59, m | b: 1.59, m | b: 1.92, m | b: 1.90, m | |
| 15 | 1.77, m | 1.80, m | 2.16, m | 2.21, m |
| 16 | 0.78, d (6.8) | 0.80, d (7.0) | 0.99, d (6.8) | 1.00, d (6.8) |
| 17 | 0.91, d (6.8) | 0.90, d (7.0) | 0.99, d (6.8) | 0.99, d (6.8) |
| # | ||||
| 18 | 1.37, s | 1.38, s | 1.65, s | 1.63, s |
| 19 | 0.98, d (6.4) | 1.00, d (6.4) | 1.40, s | 3.93, d (12.0) |
| 3.89, d (12.0) | ||||
| 20 | 1.11, s | 1.15, s | 1.12, s | 1.15, s |
Spectra were measured in CDCl3 (400 MHz);
Spectra were measured in C6D6 (400 MHz).
Figure 31H NMR chemical shift differences of MTPA esters of 6.
Figure 4Effect of compounds 1–8 at 110 μM on the LPS-induced pro-inflammatory iNOS and on COX-2 protein expression of RAAW264.7 macrophage cells by immunoblot analysis. (A) Immunoblots for iNOS and β-actin, and relative density of iNOS; (B) Immunoblots for COX-2 and β-actin, and relative density of COX-2. The values are means ± SEM (n = 6). The relative intensity of the LPS alone stimulated group was taken as 100%. Under the same experimental conditions, 10 μM CAPE (caffeic acid phenethyl ester; Sigma Chemical Company, St. Louis, MO, USA) reduced the levels of the iNOS and COX-2 protein to 0.8 ± 4.5% and 75.6 ± 12.2%, respectively, relative to the control cells stimulated with LPS. * Significantly different from lipopolysaccharide (LPS) alone stimulated group (P < 0.05).